Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Teva Pharmaceutical Industries ADR
(NY:
TEVA
)
17.95
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Teva Pharmaceutical Industries ADR
< Previous
1
2
...
13
14
15
16
17
18
19
20
21
...
24
25
Next >
West Virginia Says J&J, Teva, AbbVie Caused 'Tsunami' Of Opioid Addiction: Reuters
April 04, 2022
West Virginia's attorney general urged a judge to hold Johnson & Johnson (NYSE: JNJ), Teva Pharmaceuticals Industries Ltd (NYSE: TEVA), and AbbVie Inc's (NYSE:
Via
Benzinga
Teva to Present New Analyses of AJOVY® (fremanezumab-vfrm) Injection and AUSTEDO® (deutetrabenazine) Tablets at 2022 American Academy of Neurology Annual Meeting
April 01, 2022
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
CVS Health, Teva Settle Florida State's Opioid-Related Claims: Report
March 30, 2022
Florida has reached more than $878 million in settlements with CVS Health Corp (NYSE: CVS) and three drug companies to resolve claims and avert a trial next month over their roles in fueling an opioid...
Via
Benzinga
Teva Reaches Agreement With Florida to Settle the State’s Opioid-Related Claims
March 30, 2022
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Why Are Teva Pharmaceutical Shares Trading Higher Today?
February 09, 2022
Teva Pharmaceutical Industries Ltd's (NYSE: TEVA)
Via
Benzinga
The Struggles Continue For Generic Drugs Behemoth Teva Pharmaceutical
February 09, 2022
Teva reported light fourth-quarter sales as its own generic drugs struggled and Copaxone sales tumbled.
Via
Investor's Business Daily
Monday Markets News
March 28, 2022
Japanese Takeda TAK shares failed to thrive after its edema prevention drug was approved.
Via
Talk Markets
Friday Markets News
March 25, 2022
Methane leaks in the Permian Basin are 6 times higher than estimates.
Via
Talk Markets
Rhode Island Announces $107M Opioid Settlements With Teva, Allergan: Reuters
March 22, 2022
Rhode Island's attorney general announced settlements worth $107 million against Teva Pharmaceutical Industries Ltd (NYSE: TEVA) and AbbVie Inc's (NYSE: ABBV) Allergan unit to resolve claims over
Via
Benzinga
Lucky Day
March 21, 2022
Today Alleghany rose nearly 25% because it is being bought by Berkshire Hathaway, Warren Buffett's fund.
Via
Talk Markets
Teva Reaches Agreement With Rhode Island to Settle Opioid-Related Claims
March 21, 2022
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
35 Generic Drugmakers Sign To Manufacture Low-Cost Version Of Pfizer's COVID Pill
March 17, 2022
Via
Benzinga
Hopes For A Peace Accord
March 14, 2022
The winner today was BioNTech up 14.89% on hopes for new sales for the Covid-19 variant.
Via
Talk Markets
Rhode Island's Opioid Trial Against Teva Begins Today: Reuters
March 14, 2022
The first trial in Rhode Island state court against Teva Pharmaceutical Industries Ltd's (NYSE: TEVA) alleged responsibility for the opioid crisis begins jury...
Via
Benzinga
7 Drug Stocks to Consider After the Viatris Plunge
March 10, 2022
As Viatris and other generic drug makers plunge, what should you buy instead? Consider these seven well-known drug stocks, all of which are good value in what's still a pricey market.
Via
InvestorPlace
Stocks That Hit 52-Week Lows On Friday
March 04, 2022
On Friday, 368 stocks hit new 52-week lows. Interesting Points From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was...
Via
Benzinga
Viatris To Pay $264M As EpiPen Antitrust Litigation Settlement: Reuters
February 28, 2022
Viatris Inc (NASDAQ: VTRS), previously known as Mylan, has agreed to pay $264 million to resolve a class-action lawsuit alleging it engaged in a scheme to delay...
Via
Benzinga
Putin on the brink
February 28, 2022
For the first time in history, Swiss banks have penalized account owners for political actions and joined a SWIFT boycott.
Via
Talk Markets
Red Ink
February 24, 2022
There is little joy in stocks today as even companies reporting good results are being hit by fear of Ukraine sanctions.tbph
Via
Talk Markets
A Receding tide
February 23, 2022
Sanofi and GlaxoSmithKline have developed a new Covid-19 vaccine which they claim is 100% efficient.
Via
Talk Markets
Psychedelic Drugs Market Growing as Prevalence of Mental Health Issues are Increasing Globally
February 24, 2022
Palm Beach, FL –– February 24, 2022 – FinancialNewsMedia.com News Commentary – The prevalence of mental health disorders has risen exponentially but the development of novel medications has not kept...
Via
FinancialNewsMedia
Exposures
COVID-19
World Markets News For Thursday
February 17, 2022
Ericsson stock lost another 5.27% today in US markets.
Via
Talk Markets
Global Cannabis Extract Market To Surpass $38B By 2030, Key Players Include Tilray, Canopy Growth, Aurora
February 17, 2022
According to Coherent Market Insights, the global cannabis extract market is estimated to be valu...
Via
Benzinga
Israeli Study Reveals Promising Medical Cannabis Results, Especially For PTSD Treatment
February 16, 2022
A recent clinical trial conducted by Soroka University Medical Center and Israeli medical cannabis company Cannbit-Tikun O...
Via
Benzinga
World Markets News For Monday
February 14, 2022
European markets were down over fear of Ukrainian battles.
Via
Talk Markets
Nuclear Winter
February 11, 2022
Mexico is raising interest rates to 6%, from 5.5%.
Via
Talk Markets
Inflation inflating
February 10, 2022
The Fed will be raising interest rates soon and this will chop the appeal of investments in more vulnerable yield plays.
Via
Talk Markets
Dampening Exuberance
February 09, 2022
The bond sell-off halted today but the Fed's plans mean this will resume.
Via
Talk Markets
The Daily Biotech Pulse: Bristol-Myers Squibb Announces $5B Accelerated Buyback, Qiagen Reaps COVID Testing Windfall, WORLDSymposium Presentations Kick In
February 09, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Teva Pharmaceutical: Q4 Earnings Insights
February 09, 2022
Teva Pharmaceutical Industries (NYSE:TEVA) reported its Q4 earnings results on Wednesday, February 9, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
< Previous
1
2
...
13
14
15
16
17
18
19
20
21
...
24
25
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.